A Catalyst-penned article on Trump’s deregulatory agenda has earned a spot on the list of top 10 most popular articles for Pharmaceutical Online in 2017, as well as its sister publication Bioprocess Online. The article, by Catalyst President Nancy Bradish Myers and Vice President Anne McNickle, explores President Trump’s deregulatory executive orders and accompanying Office of Management and Budget (OMB) guidance, and analyzes the implications for FDA and innovator companies.
